Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients

American Journal of Hypertension

Volumn 18, Issue 1, 2005, Pages 30-35

  Della Mea, Paolo ^a   Lupia, Mario ^a   Bandolin, Valentina ^a   Guzzon, Samuele ^a   Sonino, Nicoletta ^a   Vettor, Roberto ^a   Fallo, Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

24 h blood pressure; Adiponectin; insulin resistance; left ventricular mass

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLE; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; FLOW RATE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HEART RATE; HEART VENTRICLE WALL; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; MALE; MEASUREMENT; MODEL; NIGHT; OBESITY; PATIENT; POPULATION; PRIORITY JOURNAL; RISK FACTOR; STRUCTURE ANALYSIS; THICKNESS; TIME; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 13244299276     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.08.029     Document Type: Article

References (40)

1. E. Ferrannini, G. Buzzicoli, R. Bonadonna, M.A. Giorico, M. Oleggini, L. Graziadei, R. Pedrinelli, L. Brandi, S. Bevilacqua Insulin resistance in essential hypertension N Engl J Med 317 1987 350 357
2. L. Lind, C. Berne, H. Lithell Prevalence of insulin resistance in essential hypertension J Hypertens 13 1995 1457 1462
3. R. Donnelly, J.M.C. McConnell Insulin resistance possible role in the aetiology and clinical course of hypertension Clin Sci 83 1992 265 275
4. A.G. Pittas, A.J. Nandini, A.S. Greenberg Adipocytokines and insulin resistance J Clin Endocrinol Metab 89 2004 447 452
5. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, P.A. Tatarani Hypoadiponectinemia in obesity and type 2 diabetes close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001 1930 1935
6. M. Matsubara, S. Maruoka, S. Katayose Decreased plasma adiponectin concentrations in women with dyslipidemia J Clin Endocrinol Metab 87 2002 2764 2769
7. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, Y. Okamoto, H. Iwahashi, H. Kuriyama, N. Ouchi, K. Maeda, M. Nishida, S. Kihara, N. Sakai, T. Nakajima, K. Hasegawa, M. Maraguchi, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Hanafusa, Y. Matsuzawa Plasma concentrations of a novel adipose-specific- protein, adiponectin, in type 2 diabetic patients Arterioscl Thromb Vasc Biol 20 2000 1595 1599
8. K.C. Huang, C.L. Chen, L.M. Chaung, S.R. Ho, T.Y. Tai, W.S. Yang Plasma adiponectin levels and blood pressures in nondiabetic adolescent females J Clin Endocrinol Metab 88 2003 4130 4134
9. F. Mallamaci, C. Zoccali, F. Cuzzola, G. Tripepi, S. Cutrupi, S. Parlongo, S. Tanaka, N. Ouchi, S. Kihara, T. Funahashi, Y. Matsuzawa Adiponectin in essential hypertension J Nephrol 15 2002 507 511
10. T. Kazumi, A. Kawaguchi, K. Sakai, T. Hirano, G. Yoshino Young man with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure Diabetes Care 25 2002 971 976
11. M. Adamczak, A. Wiecek, T. Funahashi, J. Chudek, F. Kokot, Y. Matsuzawa Decreased plasma adiponectin concentration in patients with essential hypertension Am J Hypertens 16 2003 72 75
12. M. Furuhashi, N. Ura, K. Higasshiura, H. Murakami, M. Tanaka, N. Moniwa, D. Yoshida, K. Shimamoto Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension Hypertension 42 2003 76 81
13. D. Rizzoni, M.L. Muiesan, G. Montani, R. Zulli, S. Calebich, E. Agabiti-Rosei Relationship between initial cardiovascular structural changes and daytime and night-time blood pressure monitoring Am J Hypertens 5 1992 180 186
14. J.W. Chen, S.L. Jen, W.L. Lee, N.W. Hsu, S.J. Lin, C.T. Ting, M.S. Chang, P.H. Wang Differential glucose tolerance in dipper and nondipper essential hypertension Diabetes Care 21 1998 1743 1748
15. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension J Hypertens 17 1999 151 183
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 21 Suppl 1 1998 S5 S19
17. National Institutes of Health, National Heart, Lung and Blood Institute Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults the evidence report Obes Res 6 Suppl 2 1998 S51 S210
18. E. O'Brien, J. Sheridan, K. O'Malley Dippers and non-dippers Lancet 2 1988 397
19. P. Verdecchia, C. Porcellati, G. Schillaci, C. Borgioni, A. Ciucci, M. Battistelli, M. Guerrieri, C. Gatteschi, I. Zampi, A. Santucci, C. Santucci, G. Reboldi Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension Hypertension 24 1994 793 801
20. F. Fallo, L. Barzon, M. Boscaro, E. Casiglia, N. Sonino Effect of octreotide on 24-h blood pressure profile in acromegaly Am J Hypertens 11 1998 591 596
21. D.J. Sahn, A. DeMaria, J. Kisslo, A. Weyman The Committee on M-mode standardization on the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurement Circulation 58 1978 1072 1083
22. A. Ganau, R.B. Devereux, M.J. Roman, G. de Simone, T.G. Pickering, P.S. Saba, P. Vargiu, I. Simongini, J.H. Laragh Patterns of left ventricular hypertrophy and geometric remodelling in arterial hypertension Am J Coll Cardiol 19 1992 1550 1558
23. R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, I. Sachs, N. Reichek Echocardiographic assessment on left ventricular hypertrophy comparison to necropsy findings Am J Cardiol 57 1986 450 458
24. G. de Simone, S.R. Daniels, R.B. Devereux, R.A. Meyer, M.J. Roman, O. de Divitiis, M.H. Alderman Left ventricular mass and body size in normotensive children and adults assessment of allometric relations and of the impact of overweight J Am Coll Cardiol 20 1992 1251 1260
25. M.L. Muiesan, M. Lupia, M. Salvetti, C. Grigoletto, N. Sonino, M. Boscaro, E. Agabiti-Rosei, F. Mantero, F. Fallo Left ventricular structural and functional characteristics in Cushing's syndrome J Am Coll Cardiol 41 2003 2275 2279
26. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner Homeostasis model assessment insulin resistance and β cell function from fasting plasma glucose and insulin concentration in man Diabetologia 23 1985 412 419
27. M.C. Lansang, G.H. Williams, J.S. Carrol Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension Am J Hypertens 14 2001 51 53
28. F. Fallo, A. Scarda, N. Sonino, A. Paoletta, M. Boscaro, C. Pagano, G. Federspil, R. Vettor Effect of glucocorticoids on adiponectin a study in healthy subjects and in Cushing's syndrome Eur J Endocrinol 150 2004 339 344
29. M. Suzuki, Y. Kimura, M. Tsishima, Y. Harano Association of insulin resistance with salt-sensitivity and nocturnal fall of blood pressure Hypertension 35 2000 864 868
30. A. Raji, G.H. Williams, X. Jeunemaitre, P.N. Hopkins, S.C. Hunt, N.K. Hollenberg, E.W. Seely Insulin resistance in hypertensive effect of salt sensitivity, renin status and sodium intake J Hypertens 19 2001 99 105
31. M.L. Delporte, T. Funahashi, M. Takahashi, Y. Matsuzawa, S.M. Brichard Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion in vitro and in vivo studies Biochem J 367 2002 677 685
32. S. Julius, S. Nesbitt Sympathetic overactivity in hypertension. A moving target Am J Hypertens 11 1996 113S 120S
33. K. Kohara, W. Nishida, M. Maguchi, K. Hiwada Autonomic nervous function in non-dipper essential hypertensive subjects evaluation by power spectral analysis of heart rate variability Hypertension 26 1995 808 814
34. C. Cuspidi, G. Macca, L. Sampieri, V. Fusi, B. Severgnini, I. Michev, M. Salerno, F. Magrini, A. Zanchetti Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients J Hypertens 19 2001 1539 1545
35. A.D. Struthers, A.D. Morris Screening for and treating left-ventricular abnormalities in diabetes mellitus a new way of reducing cardiac deaths Lancet 359 2002 1430 1432
36. T. Horio, J. Miyazato, K. Kamide, S. Takiuchi, Y. Kawano Influence of low-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension Am J Hypertens 16 2003 938 944
37. H. Shunkert Obesity and target organ damage the heart Obes Relat Metabol Disord 26 Suppl 4 2002 S15 S20
38. M.L. Bots, Y. Nikitin, J.T. Salonen, P.C. Elwood, S. Malyutina, A. Freire de Concalves, J. Sivenius, A. DiCarlo, P. Lagiou, J. Tuomilehto, P.J. Koudstaal, D.E. Groebbe Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe J Epidemiol Community Health 56 Suppl 1 2002 8 13
39. A. Raji, E. Seely, S. Bekins, G.H. Williams, D.C. Simonson Rosiglitazone improves insulin resistance and lowers blood pressure in hypertensive patients Diabetes Care 26 2003 172 178
40. N. Maeda, M. Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, K. Kishida, H. Nagaretani, M. Matsuda, R. Komuro, N. Ouchi, H. Kuriyama, K. Hotta, T. Nakamura, Y. Shimomura, Y. Matsuzawa PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein Diabetes 50 2001 2094 2099